Peter, one thing that surprised me was Talpaz' comment that the response rate achieved in T315I pts was, in part, due to the shorter duration in this patient group versus non-T315I CP patients (I believe he made reference to 3 years vs 7). The implication being the earlier a patient gets on pona better. He's certainly not in the hold pona "in reserve" camp.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.